The Centers for Medicare & Medicaid Services today issued a notice updating the payment rates for inpatient psychiatric facilities for fiscal year 2017. CMS makes a net payment increase of 2.2%, or $100 million, compared to FY 2016. This includes a 2.8% market-basket, offset by cuts of 0.3% for productivity and a further Affordable Care Act-mandated cut of 0.2%, as well as a decrease of 0.1% for high-cost outlier cases. CMS also completes its transition to the most recent labor market areas issued by the Office of Management and Budget. Specifically, the agency adopted these new areas for the FY 2016 IPF prospective payment system wage index, but implemented a one-year transition. In addition, when implementing these new areas, several IPFs changed from rural to urban, thus losing eligibility for the rural payment add-on of 17%. In the FY 2016 IPF PPS final rule, CMS implemented a policy to gradually phase out the rural adjustment for these IPFs over three years. The affected IPFs received two-thirds of the rural adjustment in FY 2016, and will now receive one-third of the rural adjustment for FY 2017. CMS anticipates completing the phase-out in FY 2018. The updates will take effect Oct. 1.

Related News Articles

Headline
The Centers for Disease Control and Prevention Sept. 18 issued a health advisory on a new outbreak of Ebola in the Democratic Republic of the Congo. There are…
Headline
The Centers for Medicare & Medicaid Services Sept. 18 released a final rule on policy and technical changes to Medicare Advantage, the Medicare…
Headline
The Senate Sept. 19 failed to adopt a continuing resolution by a 44-48 vote  that would have funded the government through Nov. 21. The CR was passed by…
Headline
The Department of Health and Human Services Sept. 18 announced it will take new actions to help improve care for individuals with long COVID. They include a…
Perspective
Public
All of America’s hospitals and health systems, regardless of ownership status, size or location, provide a vast range of benefits, programs and essential…
Headline
The Food and Drug Administration released a final rule Sept. 18 that rescinds one from 2024 that applied medical device rules to laboratory-developed tests.…